Dengue prevalence in Burkina Faso in 2024

Imagine the world of science as a giant, bustling detective agency. In one corner of this agency, there's a team of specialists who track invisible invaders called "arboviruses." These aren't your average germs; they are tiny, sneaky spies that hitch a ride on mosquitoes—specifically the Aedes aegypti mosquito, which is like a tiny, flying delivery truck that picks up a virus and drops it off into a human's bloodstream when it bites. One of the most famous of these viral spies is the Dengue virus. Think of Dengue not as a single enemy, but as a gang of four distinct brothers (called serotypes), labeled DENV-1 through DENV-4. If you get bitten by a mosquito carrying one brother, your body builds a shield against him, but that shield doesn't work against his siblings. This means you can get sick again and again, and sometimes, a second infection can be much more dangerous than the first. Scientists care deeply about this because Dengue is a "re-emerging" disease, meaning it's coming back with a vengeance, turning from a rare visitor into a frequent, unwelcome guest in many parts of the world, including Africa.

Now, let's zoom in on a specific story from 2024 in Burkina Faso, a country in West Africa. A team of researchers, led by detectives from the National Reference Laboratory for Viral Hemorrhagic Fevers, decided to investigate how well Dengue was doing in their neighborhood. They didn't just guess; they looked at a massive pile of evidence: 6,048 blood samples from people who were suspected of having Dengue. It's like they opened a giant mailroom and checked every single package that looked suspicious. They used two main tools to catch the virus: a high-tech molecular scanner called RT-PCR (which finds the virus's genetic code if the infection is very fresh, like finding a fresh footprint) and an antibody test called ELISA (which looks for the body's "wanted posters" or immune response if the infection is a few days old).

Here is what their investigation revealed. First, they found that Dengue is definitely still active and circulating in Burkina Faso. Out of all the 6,048 people they tested, 562 were confirmed to have the virus. That's a "positivity rate" of about 9.29%. While that might sound low, in the world of disease tracking, it means the virus is successfully infecting nearly one in every ten people who show up with symptoms.

The detectives also noticed some interesting patterns about who was getting sick. While more women than men initially showed up at the clinics with suspected symptoms (about 54% of the suspects), the actual confirmed cases were slightly more likely to be men (50.35%). The age group that got hit the hardest was adults between 25 and 64 years old. This group made up nearly 60% of the confirmed cases. The researchers suggest this is because adults are out and about, working and moving around during the day when the mosquitoes are most active, whereas children and the elderly might stay home more or be watched over more closely.

When they looked at where the virus was hiding, the Guiriko region was the biggest hotspot, followed closely by Nando and the Kadiogo region. Interestingly, some northern regions like Liptako and Soum sent no samples at all, likely because security issues made it too dangerous for health workers to collect them.

The timing of the outbreak was also a clue. The number of people suspected of having Dengue started climbing in August, hit a massive peak in October, and then the number of confirmed cases peaked a little later in November. This lag is like a wave: the water (suspected cases) rises first, and the wave breaking (confirmed cases) happens a moment later. This timing lines up perfectly with the rainy season in Burkina Faso, when puddles form and mosquito populations explode.

Finally, the team looked at which "brother" of the Dengue gang was leading the charge. They found three serotypes co-circulating: DENV-1, DENV-2, and DENV-3. The clear leader was DENV-1, which was responsible for about 59% of the infections. There were even a few rare cases where people were infected by two brothers at the same time (co-infections), but those were very uncommon.

The paper concludes that while the situation in 2024 wasn't as explosive as the massive outbreak in 2023, the virus is still firmly established and active. The authors suggest that the slight drop in prevalence compared to the previous year might be due to better control measures, but they warn that the virus is persistent. They emphasize that to keep the "mosquito delivery trucks" from spreading the virus, the country needs to keep its surveillance sharp, improve how they catch the virus early, and keep the public aware of the risks. The data doesn't claim the problem is solved; rather, it suggests that the fight against Dengue in Burkina Faso is an ongoing battle that requires constant vigilance.